Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 230 participants.

Also called NCT01212900

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 230 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01212900
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01212900. Randomized; single masking; primary purpose treatment. Start 2010-09-30 (registry gives no type); primary completion 2016-11-30 (actual). Results posted on 2018-10-31.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
Condition
Atherosclerosis
Condition
Hypercholesterolemia
Intervention (Drug)
Statins, HMG CoA
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct01212900
Content hash
88c1011f363359b17ffc5ec27406c3784102af53a3936f40fedc8b9c091634b1